(Nasdaq: BDSX), a leading diagnostics solutions company, announced the publication of the largest lung nodule biomarker clinical validation study ever conducted. This milestone strengthens the ...

Biodesix is focused on the large, underserved lung nodule market with five Medicare-covered tests and estimates ~6 million new nodules annually; it’s expanding into targeted primary care referral ...

It can be surprising to learn that lung cancer can develop in people who have never smoked. In fact, up to 20% of lung cancers occur in people without a history of smoking. While smoking remains the ...

OXFORD, England, Feb. 27, 2026 /PRNewswire/ — Optellum, the leading AI-enabled solution for earlier lung cancer detection, is thrilled to announce that it has received Therapeutic Goods Administration ...

Lung adenocarcinoma (LUAD), the most common subtype of non-small cell lung cancer, is a form of malignant pulmonary nodule that requires clinical differentiation from benign pulmonary nodules (BPN).

Abstract: Lung cancer is among the top causes of death in the world and the timely detection of the lung nodules is key in enhancing patient outcomes. The paper introduces a computer-aided innovative ...